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The main purpose of this study was to investigate the applicability of frequency domain analysis on laser Doppler ﬂowmetry
(LDF) data recorded from the index ﬁngers of patients with carpal tunnel syndrome (CTS) and diabetic polyneuropathy (DPN).
Patients with numbness of the palm were recruited and grouped according to the results of electrophysiological examinationsinto
2×2 groups by the existence or nonexistence of CTS and/or DPN. Skin blood perfusion was recorded by LDF in both the neutral
position and the maximally ﬂexed position (the Phalen test). S-transformation was utilized to decompose the recorded data into
frequency bands,andtherelative bandpowerandpowerdispersionwere calculated.Analysisofvariancewasusedto testtheeﬀects
of DPN, CTS, and the Phalentest results. The results showed that (1) DPN decreased the absolute power and the relative power in
somefrequency bands in both positions and CTS increased the power dispersion of somefrequency bands onlyduring the Phalen
test and (2) there was no diﬀerence in the LDF results between patients with positive or negative Phalen test results.
1.Introduction
Laser Doppler ﬂowmetry (LDF) is an established technique
to measure local cutaneous blood perfusion [1], which
is simultaneously aﬀected by cardiac pumping, respira-
tion, control of the autonomic nervous system, and local
metabolism. Because each factor has its own characteristic
frequency, frequency domain analysis is an ideal technique
to separate these factors and investigate their changes in
diﬀerent conditions [2]. When transformed to frequency
domains, in the so-called power spectral analysis (PSD),
LDF data can be decomposed into ﬁve components: 2–
0.6Hz (heart rate related, HR), 0.6–0.15Hz (respiration rate
related, RR), 0.15–0.06Hz (myogenic, MUS), 0.06–0.02Hz
(neurogenic, NEU); and <0.02Hz (metabolism related,
MET) [3]. The frequency ranges and the physiological
origins of these components are almost identical to those in
heart rate variability (HRV) [4], except that the NEU and
MET components are usually not separated in the latter.
The diﬀerential eﬀects on these components may be used
toinvestigatethepathophysiologicalmechanisms ofdiseases.
For example, while diabetes causes diabetic polyneuropathy
(DPN) by reduced blood perfusion due to microvascular
angiopathy [5], the compression of median nerves in carpal
tunnel syndrome (CTS) may impair the autonomic control
of local blood perfusion in the distal innervated area [6].
CTS, caused by the local compression of the median
nerve in the carpal tunnel, is one of the most common neu-
ropathies [7]. While the idiopathic form is more common
in women of old age and those who are overweight, it is
relatedtorepetitivehandmovementsinyoungerpopulations
[8]. The patients usually complain about numbness of
the palm side of the hands, especially during repetitive
manual tasks and during sleep. On the other hand, DPN,
caused by diabetes mellitus (DM), is the most common
form of polyneuropathy [9]. DPN is a sensory predominant2 Experimental Diabetes Research
Figure 1: A hand of a subject with the custom-made apparatus to
ﬁx the wrist in the maximally ﬂexed position.
neuropathy and the numbness is most prominent at the tips
of toes and ﬁngers. Even though the distribution and the
characteristicsofthesetwodiseaseentitiesarediﬀerent,some
symptoms overlap and these two diseases may coexist. In
fact, diabetes increases the prevalence of CTS.The prevalence
of clinical CTS has been shown to be 2% in the reference
population, 14% in diabetic subjects without DPN, and
30% in those with DPN [10]. Routine electrophysiological
techniques,that is, nerveconductionvelocity(NCV)studies,
maynot beabletodetecttheexistence ofCTSinthepresence
of DPN [11].
Existing data about frequency-domain analyses of LDF
signals in DM and CTS patients are scarce. The main pur-
poses of this study were ﬁrstly to investigate the applicability
of PSD on LDF data recorded from the index ﬁnger pads
of patients with CTS and DPN and secondly to evaluate
whether PSD of LDF data can assist in the diagnosis of CTS
in DPN patients. S-transformation [12, 13], a new time-
frequency analysis tool, was adopted for calculating PSD.
2.Materialsand Methods
2.1. Subjects and Experimental Procedures. The candidate
subjects were recruited from the outpatient Clinics of
Neurology, Orthopedics, and Internal Medicine of National
Cheng Kung University Hospital (NCKUH). The inclusion
criterionwas thecomplaintofinsidious onset ofintermittent
numbness of the palm. The exclusion criteria included
stroke,structuralabnormalitiesortraumaofthewrist,estab-
lished cervical radiculopathy, liver and kidney dysfunction,
autoimmune diseases, polyneuropathies, or other peripheral
neuropathies with unknown etiology or known etiologies
other than diabetes. The study protocol was approved by the
NCKUH ethics committee on human subject study. Before
an experiment began, the purpose, the potential hazards,
and the experimental procedures were fully explained to the
subject. All participants signed written informed consent
forms. The subject’s age and sex were recorded, and body
weight and height were measured.
The glycosylated hemoglobin (HbA1c) percentage of the
serum was tested, and a value greater than 6.5% was used
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Figure 2: An example of original recordings. (a) Local blood
perfusion from laser Doppler ﬂowmetry, (b) a switch signal indi-
cating theresult of thePhalentest, (c) skintemperature of theindex
ﬁnger pad, and (d) wrist ﬂexion/extension angle.
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Figure 3: An example of transforming LDF results to frequency
domain.Upper panel: neutral positionandlower panel: Phalenma-
neuver. Abbreviations are explained in the text.Experimental Diabetes Research 3
Table 1: The basic data of the recruited subjects.
EPSN DPN CTS CTS + DPN
Number of subjects 11 12 25 24
Gender (M/F) 2/9 7/5 5/20 8/16
Age (years old) (SD) 52.9 ±10.96 0 .7 ±9.15 2 .8 ±8.46 0 .5 ±9.1
Duration of DM (year) 12.2 ±10.61 3 .9 ±9.5
HbA1c (%) 5.7 ±0.77 .9 ±1.46 .0 ±0.58 .4 ±2.0
Body weight (kg) 67.9 ±11.16 1 .8 ±11.66 2 .1 ±8.16 5 .1 ±12.5
Body height (m) 1.61 ±0.07 1.62 ±0.06 1.58 ±0.06 1.58 ±0.08
Phalen sign (−/+/#) 8/3/0 8/3/1 18/5/2 19/3/2
#: numbness appeared before the Phalen maneuver was performed.
EPSN: normal electrophysiological study.
DPN: diabetic polyneuropathy.
CTS: carpal tunnel syndrome.
Table 2: Severity of CTS in groups with CTS.
Grade 1 2 3 4 5
CTS 7 2 10 2 4
CTS+DPN 0 3 9 4 8
DPN: diabetic polyneuropathy.
CTS: carpal tunnel syndrome.
to conﬁrm the existence of DM. Routine nerve conduction
velocity studies, including F-wave latencies of the upper and
lower limbs, were performed to help establish the diagnosis
of carpal tunnel syndrome and polyneuropathy and exclude
cervical radiculopathy. Short-distance comparative sensory
nerve conduction studies were used to calculate the com-
bined sensory index (CSI) for diagnosing milder CTS [14].
We adopteda grading system [15]to deﬁne the existence and
severity of CTS. CTS with grades 2 to 6 could be established
by routine NCV studies. For those subjects with normal
routine NCV study results, CSI (>0.9) was used to establish
grade 1 CTS.
From the results of electrophysiological studies and
blood tests, the candidate subjects were assigned to one
of four groups by the existence of DPN and/or CTS,
that is, EPSN: DPN(−)CTS(−), DPN: DPN(+)CTS(−),
CTS:DPN(−)CTS(+),andDPN+CTS:DPN(+)CTS(+).The
subjectsthatcouldnotbeﬁtintothesegroupswereexcluded.
2.2. Experimental Setup. The subjects were placed in a
sitting position with the forearm and hand placed on a
table. An electrogoniometer (TSD130B, Biopac System Inc.,
www.biopac.com) was ﬁxed using tape across the dorsum
of the wrist. The LDF probe (PF4001-2 Periﬂux Master,
Perimed, www.perimed.se) was attached to the ﬁnger pad
of the index ﬁnger. A thermometer (PF4005-2 PeriTemp
Tissue Heater, Perimed, www.perimed.se) built into the LDF
probe was used to keep the surface temperature of the ﬁnger
pad at a constant value. An apparatus, custom made from
a thermoplastic material commonly used for orthoses, was
utilized to maintain the wrist in a maximally ﬂexed position.
Figure 1 shows a hand of a subject with the apparatus. The
hand and forearm were fastened to the apparatuswith Velcro
straps. The subject was instructed to push a switch with
the other hand when the sensory symptoms appeared in
the tested hand. Four signals, including the LDF signal, the
switch state, the wrist angle, and the ﬁnger pad temperature,
were digitized and recorded on a personal computer by
a commercial analog-to-digital conversion system (MP100,
Biopac System Inc., www.biopac.com)a tas a m p l i n gr a t eo f
200Hz/channel and with a total duration of 6 minutes. Two
sets of data were recorded: one with the wrist in the neutral
position and the other with the wrist in the maximally ﬂexed
position. The latter position was to simulate the Phalen test
maneuver [16].
2.3. Data Processing. The LDF signals q(k)w e r ea n a l y z e d
both in the time and the frequency domains. In the time
domain, q(k) was ﬁrst downsampled by 200 to qd(k), so that
the sampling rate would become1Hz. The time average(Av)
wascalculatedastheaverageoverthewhole recording period
(360 seconds), that is,
Av =
1
360
360  
k=1
qd[k],( 1 )
and the slope (Sp) or the trend was calculated as the slope
estimated from the least-square linear regression,
Sp =
⎛
⎝ 1
360
360  
k=1
k2
⎞
⎠
−1
·
1
360
360  
k=1
k · qd[k]. (2)
For the frequency-domain analyses, S-transformation [12,
13] was adopted,
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(3)
where S was the S-transformed result, N was the number of
sampled frequencies,F wastheFouriertransformation ofthe
N-point time series q(k), j, and n indexed the time and fre-
quency axes, respectively. S-transformation was an extension
of the Fourier transformation for the time-frequency analy-
ses. In this study, the time step was 5ms and the frequency4 Experimental Diabetes Research
Table 3: Two-way ANOVA of power ratio with wrists in the neutral position.
EPSN DPN CTS DPN+CTS PCTS
#1 PDPN
#2
QHR 0.898± 0.073 0.990 ± 0.066 0.903 ±0.082 0.951 ±0.054 .453 .027∗
QRR 0.035± 0.031 0.021 ± 0.030 0.032 ±0.029 0.019 ±0.019 .675 .045∗
QMYO 0.031± 0.026 0.014 ± 0.013 0.027 ±0.027 0.013 ±0.019 .637 .009∗
QNEU 0.027± 0.021 0.022 ± 0.028 0.030 ±0.035 0.014 ±0.016 .690 .126
QMET 0.013± 0.012 0.017 ± 0.028 0.013 ±0.015 0.006 ±0.006 .148 .636
Sp 0.010± 0.077 0.008 ± 0.019 0.018 ±0.046 0.001 ±0.037 .996 .694
Av 49.04± 27.50 31.30 ± 20.02 43.18 ±34.22 25.85 ±15.01 .578 .020∗
∗:s i g n i ﬁ c a n td i ﬀerence (P<. 05) by two-way ANOVA.
#1: P v a l u ef o rt h ei n ﬂ u e n c eo ft h ef a c t o rC T S .
#2: P v a l u ef o rt h ei n ﬂ u e n c eo ft h ef a c t o rD P N .
Table 4: Two-way ANOVA of power ratio with wrists in the maximallyﬂexed position.
EPSN DPN CTS DPN + CTS PCTS PDPN
QHR 0.881 ±0.060 0.927 ±0.059 0.900 ± 0.082 0.927 ± 0.083 .629 .058
QRR 0.042 ±0.028 0.028 ±0.034 0.031 ± 0.023 0.028 ± 0.040 .528 .300
QMYO 0.034 ±0.020 0.018 ±0.016 0.030 ± 0.026 0.018 ± 0.020 .789 .013∗
QNEU 0.036 ±0.022 0.019 ±0.015 0.031 ± 0.035 0.019 ± 0.024 .721 .036∗
QMET 0.013 ±0.009 0.014 ±0.027 0.019 ± 0.020 0.030 ± 0.065 .301 .539
Sp 0.006 ±0.026 −0.003 ± 0.027 −0.008 ±0.045 0.009 ± 0.048 .939 .694
Av 49.59 ±24.61 31.25 ±22.25 43.96 ± 31.59 31.65 ± 15.75 .676 .016∗
∗:s i g n i ﬁ c a n td i ﬀerence (P<. 05) by two-way ANOVA.
step was 0.0028Hz. The advantage of S-transformation over
short-time Fourier transformation is that, similar to wavelet
decomposition, S-transformation has better simultaneous
frequency and time resolution. The advantage over wavelet
transformation is that interpretation is easier, because the
independentvariableisdirectfrequencywithoutanyapprox-
imation.Swasatwo-dimensional arrayofcomplexnumbers.
The mean power density over time was derived,
A
 
j
 
=
1
tp
tp  
n=1
   S
 
j,n
    2,( 4 )
where tp = 72000. The power ratio (QC)f o rt h ef r e q u e n c y
band corresponding to HR, RR, MUS, NEU, and MET was
calculated as
QC =
 
k(fr(k) ∈ BC)A(k)
 
k(fr(k)∈ BT)A(k)
,( 5 )
where C indexed one of the following bands: HR, RR,
MUS, NEU, and MET, BC was the corresponding frequency
band (0.6–2Hz, 0.15–0.6Hz, 0.06–0.15Hz and 0.0095–
0.06Hz, resp.), BT was the total power over 0.0095–2Hz
and fr was the sampled frequency in the S-transformation.
The dispersion of power for the frequency band (DC)
corresponding to HR, RR, MUS, and NEU was estimated as
DC =
 
k(fr(k) ∈ BP)A(k)
 
k(fr(k) ∈ BC)A(k)
,( 6 )
where BP was the corresponding peak frequency band
(0.6–1.6Hz, 0.15–0.4Hz, 0.07–0.1Hz, and 0.02–0.05Hz,
resp.). All of the calculations were performed with Matlab
commercial software (www.mathworks.com).
2.4. Statistical Analyses. Two-way analysis of variance
(ANOVA)was used to test the eﬀectsofCTSand DPNonthe
diﬀerencesofthetime-domainparametersofLDF,respective
b a n dp o w e rr a t i o s( QC), and band power dispersions (DC)
among the groups (ESPN, CTS, DPN, CTS+DPN).One-way
ANOVA was used to test the eﬀects of a positive Phalen sign
on the diﬀerencesof respective band power ratios among the
groups.ThesigniﬁcancelevelwassetasP<. 05.Allstatistical
analyses were performed using StatView (SAS Institute Inc.,
Cary, NC, USA).
3.Results
In total, 72 subjects were included. The basic data are
summarized in Table 1. There were more females in all
groups, and the groups with DPN tended to be older. When
thesubjectswith numbnessbeforethetestwere excluded,the
overall positive rate of the Phalen test was 20.9%. Table 2
shows the distribution of subjects with CTS according to
the severity of CTS. The subjects with DPN tended to have
higher grades (P = .0 1 ) .H o w e v e r ,t h e r ew a sn os i g n i ﬁ c a n t
diﬀerence of severity between the Phalen sign positive and
negative groups (P = .29), and, by the chi-square test, there
was no signiﬁcant correlation between Phalen sign results
and DPN (P = .18).
Figure 2shows an example ofrecordingsfrom thePhalen
test. The ﬁrst (uppermost) panel shows the LDF data, which
ﬂuctuated around 20au (arbitrary unit) without an obvious
trend. The second panel shows the subjective indicator of
Phalen test results. In this case, the subject pushed the switch
at around 40 seconds. The third panel shows the surfaceExperimental Diabetes Research 5
Table 5: Two-way ANOVA of power dispersion with wrists in the neutral position.
EPSN DPN CTS DPN + CTS PCTS PDPN
DHR 0.956 ±0.048 0.958 ±0.034 0.957 ±0.029 0.921 ±0.097 .260 .287
DRR 0.698 ±0.133 0.650 ±0.102 0.654 ±0.111 0.618 ±0.115 .192 .151
DMYO 0.458 ±0.034 0.437 ±0.046 0.458 ±0.071 0.442 ±0.069 .875 .260
DNEU 0.369 ±0.129 0.434 ±0.147 0.405 ±0.132 0.388 ±0.155 .881 .511
Table 6: Two-way ANOVA of power dispersion with wrists in the maximally ﬂexed position.
EPSN DPN CTS DPN + CTS PCTS PDPN
DHR 0.949 ±0.057 0.954 ±0.036 0.958 ± 0.031 0.919 ±0.087 .400 .279
DRR 0.746 ±0.144 0.715 ±0.078 0.645 ± 0.124 0.637 ±0.112 .004∗ .517
DMYO 0.427 ±0.055 0.453 ±0.084 0.461 ± 0.064 0.470 ±0.065 .133 .319
DNEU 0.529 ±0.093 0.441 ±0.192 0.421 ± 0.130 0.408 ±0.126 .044∗ .145
∗:s i g n i ﬁ c a n td i ﬀerence (P<. 05) by two-way ANOVA.
Table 7: Eﬀects of the Phalentest result on power ratios with wrists
in the neutral position.
Negative Positive Persistent P
AHR 0.848 ± 0.061 0.834 ±0.076 0.901 ±0.025 .126
ARR 0.614 ± 0.069 0.600 ±0.053 0.577 ±0.084 .424
AMYO 0.359 ± 0.034 0.367 ±0.025 0.373 ±0.024 .450
ANEU 0.337 ± 0.046 0.348 ±0.026 0.320 ±0.041 .432
Sp 0.107 ± 0.446 0.130 ±0.257 0.125 ±0.159 .977
Av 31.49 ± 25.65 46.97 ±27.93 42.70 ±24.42 .010∗
∗:s i g n i ﬁ c a n td i ﬀerence (P<. 05) by one-way ANOVA.
Table 8: Eﬀects of the Phalentest result on power ratios with wrists
in the maximally ﬂexed position.
Negative Positive Persistent P
AHR 0.837 ±0.064 0.813 ±0.068 0.878 ±0.040 .134
ARR 0.627 ±0.068 0.618 ±0.057 0.598 ±0.088 .622
AMYO 0.369 ±0.034 0.364 ±0.027 0.371 ±0.020 .819
ANEU 0.336 ±0.057 0.334 ±0.052 0.360 ±0.028 .634
Sp 0.033 ±0.374 −0.111 ±0.310 −0.042 ±0.268 .363
Av 33.30 ±19.75 52.49 ±33.39 48.08 ±30.81 .018∗
∗:s i g n i ﬁ c a n td i ﬀerence (P< . 05) by one-way ANOVA.
temperature of the index ﬁnger pad. The controlled target
temperature was 32◦C. The fourth panel shows the wrist
ﬂexion/extension angle. The angle decreased from 77◦ to
74◦ slowly with time, meaning that the wrist was less ﬂexed.
However, the angle change was small.
Figure 3 shows an example of frequency-domain anal-
yses. The upper and lower panels show the results when
the wrist was in a neutral and maximally ﬂexed position,
respectively. When the wrist was maximally ﬂexed, the
HR peak was consistently present and its amplitude was
increased, the RR peak remained ambiguous, the amplitude
of MUS base was increased, but no clear peak was present,
and a peak appeared in the NEU band around 0.045Hz.
The results of analyzing LDF data with the wrist in
the neutral position are summarized in Table 3.T w o - w a y
ANOVA with post hoc tests showed that the diﬀerences
among the power ratios of the 4 groups were signiﬁcant for
AHR, ARR,a n dAMUS for the factor DPN. The diﬀerence in
Av was also signiﬁcant for the factor DPN, while AHR was
larger in subjects with DPN, and ARR, AMUS,a n dA vw e r e
smaller. The results with the wrist in the maximally ﬂexed
position (Table 4) showed that the diﬀerences among the 4
groupswere signiﬁcant forAMUS, ANEU, and Avfor the factor
DPN. All AMUS, ANEU, and Av values were smaller in subjects
with DPN. On the other hand, two-way ANOVA with post
hoc tests (Tables 5 and 6) showed that the diﬀerences among
the power dispersion of the 4 groups were not signiﬁcant
in any band for either factor in the neutral position and
was signiﬁcant for ARR and ANEU for the factor CTS in
the maximally ﬂexed position. ARR and ANEU were smaller,
which meant the power was more dispersed, in the subjects
with CTS.
The eﬀectsof Phalen test results onLDF parameters were
tested by one-way ANOVA with post hoc tests (Tables 7 and
8). Only Av was signiﬁcantly aﬀected by Phalen test results.
Av was smaller when the Phalen test was negative compared
to when it was positive. The results of statistical tests were
similar for the wrist in the neutral and maximally ﬂexed
positions.
4.Discussion
Frequency-domain analyses can complement time-domain
analyses in interpreting time array signals. Existing data
about PSD of LDF signals in DM and CTS patients are
scarce.Themain reasonsareprobablythatfrequencydomain
analyses are less familiar and the tools are less commonly
available to biological and medical ﬁelds. Traditionally, PSD
was performed by Fourier transformation and extension
to the time-frequency analyses, short-time Fourier trans-
formation. Newer time-frequency analysis tools such as
wavelet decomposition and S-transformation can not only
perform PSD, but also localize speciﬁc changes of frequency
powers in the time domain. As mentioned in Methods and
Materials, the advantage of S-transformation over wavelet6 Experimental Diabetes Research
transformation is that the independent variable is direct
frequency without any approximation. In this study, we
averaged the band powers over time, so the results became
equivalent to PSD. Still, the advantage of S-transformation is
that the curve of PSD is smoother.
Only one study about PSD of LDF signals in DM was
found in the literature. The study, which measured LDF
signals at the ﬁnger tip, reported that at the resting state,
there was a signiﬁcant diﬀerence in the absolute but not in
t h er e l a t i v es c a l o g r a me n e r g y between the normal and the
type I DM groups for all three frequency bands (MYO, NEU,
and MET) [2]. These results are diﬀerent from ours, which
showed that the relative band powers of two bands (RR and
MYO) were decreased and Av, which was equivalent to the
absolute total power, was also decreased. Several diﬀerences
in methodology might explain this diﬀerence. First, while
the cited study recruited type I DM patients who were
younger and without particular emphasis on the existence
of neuropathy, we recruited type II DM patients with
deﬁniteDPN and sensory symptoms. Second,the citedstudy
recorded LDF at a lower sampling rate (3Hz) for a longer
time (1000 seconds), while we used a higher sampling rate
(200Hz) for a shorter time (360 seconds). A lower sampling
rate saves storage space, facilitating a long recording time
and increasing the resolution of lower frequencies, at the
cost of losing information on higher frequencies and at a
risk of aliasing. We used a higher sampling rate, so that
all ﬁve known bands could be analyzed at the cost of a
shorterrecording timeand alowerlow-frequencyresolution.
Third, while the cited study used the total energy between
0.0095Hz and 0.145Hz for normalization, we used the total
energybetween0.0095Hzand 2Hzfornormalization. There
are more existing data about frequency-domain analyses of
HRV signals in DM patients. Stefanovska and Braˇ ciˇ c[ 17]
indicated that the human cardiovascular system is governed
by ﬁve coupled oscillators. Thus, frequency-domain analyses
of both heart rate variability and skin blood perfusion (LDF)
reveal ﬁve similar frequency bands, though the controlling
factors might be diﬀerent. While skin blood perfusion is
governed more by local factors, heart rate variability is inﬂu-
enced more by global factors. Though the aﬀected frequency
bandshavebeendiﬀerent,thecommonconclusionofstudies
on frequency domain analysis of HRV in DM patients has
been that DM decreases the absolute and relative band
powersinsome frequencybands, especially HFand LFbands
[18–24].Infact,becausetheRRandMYObandscorrespond,
respectively, to the HF and LF bands of HRV, our results
are compatible with the existing data from the literature
about HRVin DM. In addition, because the statistical results
were similar in both neutral and maximally ﬂexed positions,
our results imply that the blood perfusion was decreased
by DPN but was not inﬂuenced by the increase of carpal
tunnel pressure. The explanation is that main arteries to
the ﬁngers (radial and ulnar arteries) are exterior to the
carpal tunnel and will not be directly compressed by the
increase ofcarpaltunnelpressure.However,perfusion can be
compromised dueto thedysfunction of theautonomic ﬁbers
in the compressed median nerve. Our results also imply
that for normal and DPN subjects, the increase of carpal
tunnel pressure during the Phalen test was not high enough
to compromise the function of autonomic ﬁbers. In fact,
there is a study indicating that nerve ﬁbers in hyperglycemia
a r em o r er e s i s t a n tt oi s c h e m ic conduction block during
compression [25].
ThereisonlyonestudyaboutLDFinCTSpatients,which
is basedontime-domain analyses. Schuindetal.[26]s ho w ed
that, after carpal tunnel release, the arterial blood ﬂow to the
hand was increased. Our results showed that CTS did not
aﬀect the relative powerratio in any frequency band in either
the neutral or the maximally ﬂexed position.
To the best of our knowledge, there are no documented
studies about power dispersion in each frequency band.
However, less power dispersion implies less variability of the
frequency and less control action. Therefore, we developed
t h i sp a r a m e t e rt oe v a l u a t et h ec o n t r o le ﬀort of the local
cardiovascular system. In the maximally ﬂexed wrist posi-
t i o n ,t h et u n n e lp r e s s u r ew a se x p e c t e dt oi n c r e a s e ,l e a d i n g
to a decrease of blood supply to the median nerve and
a compromise of its functions. However, the LDF results
indicate that the absolute total power and the relative band
power did not change in the maximally ﬂexed position,
while the relative power was more dispersed in the RR
and NEU bands in the CTS group. The results imply that
local perfusion did not decrease and maintained a similar
oscillation pattern in both positions, although more control
eﬀort was needed to maintain the pattern in the maximally
ﬂexed position for the CTS patients. We think the possible
explanations for the preserved control are that (1) the
increase of carpal tunnel pressure during the Phalen test was
not high enough to compromise the function of autonomic
ﬁbers or (2) the diameter of autonomic ﬁbers is relatively
small, and there were evidences [27, 28] that ﬁbers of larger
diameter were damaged ﬁrst in CTS. Sp was very small for
all groups, which also indicates that there was no particular
trend during the recording course.
Though some studies have indicated that the Phalen
test is more reliable than other manual tests, the sensitivity
(76%, ranging from 34 to 92%) and speciﬁcity (51%) are
not satisfactory [29, 30]. Evenin normal subjects, the Phalen
t e s tm a yb ep o s i t i v ei n2 6 %o fs u b j e c t s[ 31]. The main
underlying mechanism of this test is believed to be due to
the increased intra tunnel pressure during the wrist ﬂexion,
causing more compression of the median nerve. The Phalen
test is inherently a qualitative test, because the compression
pressureisnotaccuratelydeﬁned.Inaddition,forthosemore
severe patients with persistent numbness, the Phalen test
is undeﬁned, and for those patients with hypoesthesia, the
results may be negative. One study reported that the Phalen
test might be abettertestfor tenosynovitis thanCTS[32].All
of these factors together may explain the low sensitivity and
speciﬁcity of the Phalen test.
The ﬁnding that Av,representing the total perfusion, was
larger in patients with a positive Phalen sign (Tables 7 and
8) implies that the test might be more suitable for those with
milder severity. As the disease exacerbates and Av decreases,
the numbness becomespersistent. When the nerve functions
are more compromised, hypoesthesia becomes predominant
and the patients might not feel numbness.Experimental Diabetes Research 7
There are several limitations in interpreting the results of
this study. First, the simple apparatus adopted in this study
could not ensure that the wrist was maintained at the same
anglethroughouttheexperiment.However,becausethedrift
was small and the tunnel pressure was a continuous function
of wrist angle [33], the tunnel pressure was still markedly
increased throughout the test. The results of Sp, which were
very small for all groups, were also indicative that the small
drift of the wrist angle might not have a signiﬁcant eﬀect
on LDF recording. Second, the patients with DPN tended to
be older, and there were more females in all groups except
in the DPN group (Table 1). However, when these factors
were set as confounding factors in the statistical analyses, the
conclusions were similar. In addition, the review of Bircher
et al. [34] indicated that age had no eﬀect and sex had a
minor or no eﬀect on LDF recording of the skin. Third, LDF
recording of a small area is characterized by a great temporal
and spatial heterogeneity and, therefore, low reproducibility.
The recently developed technique of laser Doppler perfusion
imaging [35, 36] may partly ameliorate the problem, at the
cost of longer recording time. It is also possible that the
procedures developed in this paper can be extended to the
data of perfusion imaging when the recording time and the
size of recording area are properly chosen.
5.Conclusions
The results of this study showed that, in boththe neutral and
the maximally ﬂexed wrist positions, the total perfusion and
some components of power spectral analysis were signiﬁ-
cantlydecreasedindiabeticpolyneuropathybutnotincarpal
tunnel syndrome, and, in contrast, some components of
power spectral analysis were more dispersed in carpal tunnel
syndrome in the maximally ﬂexed position. In summary,
while more research is needed, power spectral analysis of
laserDopplerﬂowmetry datain conjunctionwith the Phalen
test may be a new tool for studying carpal tunnel syndrome
in diabetic polyneuropathy patients.
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